Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Patients with established cardiovascular disease (heart attack, stroke history) who benefit from semaglutides proven MACE reduction (SELECT trial) Adolescents aged 1217 with obesity Wegovy is the only approved GLP-1 option in this age group Patients who prefer or need an oral medication option (Rybelsus tablets for type 2 diabetes) Those for whom semaglutide is more affordable or better covered by insurance Patients with metabolic dysfunction-associated steatohepatitis (MASH) Wegovy HD received approval for this indication in 2025 First-time GLP-1 users who want to start with the medication with the longest real-world safety track record Frequently Asked Questions Is tirzepatide stronger than semaglutide
The WHO: Officially validated GLP-1 receptor agonists (semaglutide, tirzepatide and liraglutide) as effective treatments for obesity in adults with a BMI of 30 or more
Starting both simultaneously significantly increases the risk of severe nausea, electrolyte imbalances, and dangerously low caloric intake
Why it's for you Entry pricing from $129/mo for compounded semaglutide and $199/mo for compounded GLP-1/GIP
Typically, the frequency does not change
The clinic serves men and women in the Nashville, Tennessee, region by treating chronic medical issues to achieve healthier aging
